EP4698532A1 - Imidazotriazinderivate als il-17-modulatoren - Google Patents

Imidazotriazinderivate als il-17-modulatoren

Info

Publication number
EP4698532A1
EP4698532A1 EP24720077.7A EP24720077A EP4698532A1 EP 4698532 A1 EP4698532 A1 EP 4698532A1 EP 24720077 A EP24720077 A EP 24720077A EP 4698532 A1 EP4698532 A1 EP 4698532A1
Authority
EP
European Patent Office
Prior art keywords
formula
compound
pharmaceutically acceptable
acceptable salt
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24720077.7A
Other languages
English (en)
French (fr)
Inventor
Gregory William HASLETT
James Thomas Reuberson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of EP4698532A1 publication Critical patent/EP4698532A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP24720077.7A 2023-04-17 2024-04-15 Imidazotriazinderivate als il-17-modulatoren Pending EP4698532A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2305585.8A GB202305585D0 (en) 2023-04-17 2023-04-17 Therapeutic agents
PCT/EP2024/060131 WO2024218030A1 (en) 2023-04-17 2024-04-15 Imidazotriazine derivatives as il-17 modulators

Publications (1)

Publication Number Publication Date
EP4698532A1 true EP4698532A1 (de) 2026-02-25

Family

ID=86497343

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24720077.7A Pending EP4698532A1 (de) 2023-04-17 2024-04-15 Imidazotriazinderivate als il-17-modulatoren

Country Status (12)

Country Link
EP (1) EP4698532A1 (de)
KR (1) KR20250170130A (de)
CN (1) CN121039130A (de)
AR (1) AR132433A1 (de)
AU (1) AU2024257382A1 (de)
CL (1) CL2025003161A1 (de)
CO (1) CO2025014317A2 (de)
GB (1) GB202305585D0 (de)
IL (1) IL323948A (de)
MX (1) MX2025012309A (de)
TW (1) TW202446365A (de)
WO (1) WO2024218030A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009204441B2 (en) 2008-01-09 2015-03-05 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of ocular inflammatory disorders
GB201909190D0 (en) 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
AR126255A1 (es) 2021-07-01 2023-10-04 UCB Biopharma SRL Derivados de imidazotriazina como moduladores de il-17

Also Published As

Publication number Publication date
CL2025003161A1 (es) 2025-12-12
CO2025014317A2 (es) 2025-10-30
MX2025012309A (es) 2025-11-03
GB202305585D0 (en) 2023-05-31
AU2024257382A1 (en) 2025-10-09
WO2024218030A1 (en) 2024-10-24
AR132433A1 (es) 2025-06-25
TW202446365A (zh) 2024-12-01
CN121039130A (zh) 2025-11-28
KR20250170130A (ko) 2025-12-04
IL323948A (en) 2025-12-01

Similar Documents

Publication Publication Date Title
EP3893871B1 (de) Benzimidazolonderivate und analoge davon als il-17-modulatoren
CN102369200B (zh) 5元杂环化合物的氮杂螺烷基-烷基氨基甲酸酯衍生物、其制备方法和其治疗用途
CA3119002A1 (en) Functionalised amine derivatives as il-17 modulators
US20210017155A1 (en) Pyrimidinyl tyrosine kinase inhibitors
JP2022538519A (ja) Ｉｌ－１７調節剤としてのイミダゾピリジン誘導体
WO2021170631A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2024126250A1 (en) Imidazotriazine derivatives as il-17 modulators
US20230399328A1 (en) Dicyclopropylmethyl derivatives as il-17 modulators
WO2024017880A1 (en) Imidazotriazine derivatives as il-17 modulators
WO2024126248A1 (en) Imidazotriazine derivatives as il-17 modulators
AU2024257382A1 (en) Imidazotriazine derivatives as il-17 modulators
WO2024126249A1 (en) Imidazotriazine derivatives as il-17 modulators
WO2024218032A1 (en) Imidazotriazine derivatives as il-17 modulators
JP2026514760A (ja) Ｉｌ－１７モジュレーターとしてのイミダゾトリアジン誘導体
JP2026514784A (ja) Ｉｌ－１７モジュレーターとしてのイミダゾトリアジン誘導体
JP6757332B2 (ja) ＲＯＲｃモジュレーターとしてのピリダジン誘導体
WO2026073937A1 (en) Imidazotriazine derivatives as il-17 modulators
WO2026073936A1 (en) Imidazotriazine derivatives as il-17 modulators
JP6757333B2 (ja) ＲＯＲｃモジュレーターとしてのピリダジン誘導体

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR